The short version of cjc-1295 fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2025-11-15 and is reviewed periodically as new material appears.
Both forms act at the pituitary receptor for growth hormone-releasing hormone and increase growth hormone output, which in turn raises insulin-like growth factor 1. A long-acting analog produces sustained rather than pulsatile stimulation, and the physiological consequences of that pattern are not fully settled. Published human data on the extended form remain limited, and much of what circulates in discussion traces to early company reports rather than independent replication. How sustained exposure affects normal feedback remains an open question.
The distinguishing feature of the DAC form is a maleimide-containing group that reacts with the free thiol of cysteine-34 on human serum albumin. This reaction forms a covalent bond without enzymatic assistance, and it takes place after the peptide enters the bloodstream. Because albumin is abundant and long-lived, the attached peptide is carried through circulation far longer than an unmodified fragment would survive. The chemistry is a deliberate pharmacokinetic strategy rather than a change to receptor activity.
Enzymatic protection is a separate mechanism from plasma protein binding. The four substitutions in the backbone reduce recognition by dipeptidyl peptidase IV, which normally cleaves the natural hormone within minutes. Without the reactive group, this resistance still yields only a short window of activity, generally reported in the range of tens of minutes. With it, reported half-lives in early human work extended to several days. The size of that gap is the main practical distinction between the two materials.
The second form adds a maleimide-bearing linker to the lysine at the carboxyl end. This group reacts with cysteine-34 on circulating serum albumin, forming a covalent bond that keeps the peptide in the bloodstream for far longer. ConjuChem developed the molecule as a way to extend the action of a peptide without frequent administration. The albumin attachment is the defining structural feature of the drug affinity complex version. Whether continuous exposure produces effects distinct from shorter pulses remains an unresolved research question.
CJC-1295 belongs to a family of synthetic peptides modeled on growth hormone-releasing hormone, the hypothalamic signal that prompts the pituitary to release growth hormone. The compound is built from the first twenty-nine amino acids of the natural human sequence, a fragment that retains full receptor binding capacity. Native growth hormone-releasing hormone is degraded quickly in circulation, so the fragment alone has limited practical value. Early work therefore focused on chemical modifications that preserve receptor binding while slowing enzymatic breakdown. The result is a molecule described in the literature as a long-acting analog of the natural hormone.
| Property | Value | Notes |
|---|---|---|
| Duration with linker | Several days | Reported in early human work |
| Duration without linker | Tens of minutes | Short plasma residence |
| Albumin attachment site | Cysteine-34 | Covalent maleimide reaction |
| Primary receptor | Pituitary GHRH receptor | Stimulates growth hormone release |
| Downstream marker | Insulin-like growth factor 1 | Indirect measure of activity |
At the pituitary, the peptide binds the growth hormone-releasing hormone receptor on somatotroph cells. Receptor activation raises intracellular cyclic AMP and triggers release of stored growth hormone. Somatostatin and other hypothalamic signals modulate this response. Negative feedback from insulin-like growth factor 1 also influences output. The same regulatory architecture operates with the native hormone. Whether the synthetic analog alters feedback dynamics over repeated exposure remains an open question. Most published receptor work uses cell models rather than intact human systems.
CJC-1295 is a synthetic peptide belonging to the growth hormone-releasing hormone analog family. It comprises twenty-nine amino acid residues derived from the N-terminal region of natural GHRH. The molecule incorporates several non-natural substitutions that increase resistance to enzymatic degradation. These modifications extend its activity compared with the native hormone fragment. Researchers use it to study pituitary growth hormone secretion in laboratory and clinical settings. This compound is distinct from native GHRH in its stability profile.
Reports on this compound commonly follow serum growth hormone and insulin-like growth factor 1 across defined time windows. Protocols differ in sampling frequency, assay platform, and participant characteristics, which makes direct comparison between publications difficult. Some work focuses on pulsatile release patterns instead of average concentrations. Whether repeated exposure alters endogenous hormone rhythms over long periods remains an open question, and the formal literature is thinner than the volume of informal commentary implies.
Once in circulation, the peptide binds the growth hormone-releasing hormone receptor displayed on pituitary somatotroph cells. Receptor activation couples to Gs proteins, elevates intracellular cyclic AMP, and drives protein kinase A signaling inside the cell. That cascade increases discharge of growth hormone into the bloodstream. The analog therefore operates through a receptor pathway that already exists for the body's own releasing hormone, rather than through an engineered artificial target.
Identity and purity are assessed mainly by reversed-phase high-performance liquid chromatography combined with mass spectrometry. The chromatographic separation resolves the target peptide from truncation products and from species carrying oxidised residues, while mass measurement confirms the expected molecular mass. Because the two common variants differ by roughly 280 daltons, a mass determination distinguishes them unambiguously. Purity is often quoted as a percentage of total peak area, although that figure depends on the detection wavelength and the integration method applied.
Reported half-lives differ widely between the two variants and between species. Values for the albumin-binding form are usually expressed in days, while the unconjugated form is measured in minutes to a few hours. Sampling schedules, assay sensitivity, and route of administration all influence the numbers, which limits direct comparison across studies. Whether sustained receptor occupancy produces different downstream effects from pulsatile stimulation remains an open question in the published work. Claims about relative potency should therefore be read alongside the specific study design that produced them.
Lyophilised powder is the usual supplied form. The material is hygroscopic, so vials are typically equilibrated to room temperature before opening in order to prevent condensation on the contents. Long-term storage is generally described at minus twenty degrees Celsius or colder, protected from light and moisture. Repeated freeze-thaw cycles are avoided because they promote aggregation and loss of soluble material. A reconstituted solution is considerably less stable than the dry powder and is normally kept refrigerated for short periods only.
Rainer Lisiewicz (1 July 2004 – 12 May 2009) Jörg Seydler (12 May 2009 – 29 November 2009) Uwe Trommer (29 November 2009 – 30 June 2010) – Caretaker Joachim Steffens (1 July 2010 – 7 June 2011) Mike Sadlo (7 June 2011 – 7 December 2011) Willi Kronhardt (3 January 2012 – 30 June 2012) Marco Rose (1 July 2012 – 30 June 2013) Carsten Hänsel (1 July 2013 – 23 September 2013) Heiko Scholz (8 October 2013 – 23 September 2018) Björn Joppe (27 September 2018 – 17 December 2018) Rainer Lisiewicz (18 December 2018 – 19 October 2019) Wolfgang Wolf (20 October 2019 – 30 June 2020) Almedin Civa (1 July 2020 – 19 February 2024) Tomislav Piplica (19 February 2024 – 30 June 2024) Jochen Seitz (1 July 2024 – 30 June 2026) Torsten Ziegner (since 1 July 2026 –)
Aquaculture topic page from Woods Hole Oceanographic Institution "Aquaculture Factsheet". Waitt Institute. 4 June 2015. Archived from the original on 2015-06-17. Retrieved 2015-06-08. The Coastal Resources Center NOAA aquaculture The University of Hawaiʻi's AquacultureHub
Unlike classes I and II, Class III molecules have physiological roles and are encoded between classes I and II on the short arm of human chromosome 6. Class III molecules include several secreted proteins with immune functions: components of the complement system (such as C2, C4, and B factor), cytokines (such as TNF-α, LTA, and LTB), and heat shock proteins.
At menopause, breast atrophy occurs. The breasts can decrease in size when the levels of circulating estrogen decline. The adipose tissue and milk glands also begin to wither. The breasts can also become enlarged from adverse side effects of combined oral contraceptive pills. The size of the breasts can also increase and decrease in response to weight fluctuations. Physical changes to the breasts are often recorded in the stretch marks of the skin envelope; they can serve as historical indicators of the increments and the decrements of the size and volume of a woman's breasts throughout the course of her life. Breast changes during menopause are sometimes treated with hormone replacement therapy.
Sources: en.wikipedia.org
Carrie Ann Inaba (singer-actress) is the US national awareness ambassador and spokesperson for the Sjögren's Foundation (previously the Sjögren's Syndrome Foundation). Venus Williams (world champion tennis player) has been diagnosed with Sjögren's disease and said she had struggled with fatigue for years. Stephen McPhail (professional soccer player for Ireland, Leeds, and Cardiff City) was diagnosed with lymphoma and Sjögren's disease at age 29. Halsey (American singer) was diagnosed with Sjogren's, Ehlers–Danlos syndrome, mast cell activation syndrome, and postural orthostatic tachycardia syndrome. Slađana Milošević (Serbian singer) died after struggling with Sjögren's disease.
== Art == The continuity of the deep fasciae within the human body inspired the artistic expression seen in the Fascial Net Plastination Project, which is prominently displayed at the Body Worlds exhibition in Berlin.
Carbohydrates are usually present, often in a mix of simple sugars like glucose and more complex oligosaccharides such as maltodextrin which are supposed to provide more sustained energy. Carbohydrates cause an increase in serotonin levels. These are used both to provide a sweet taste and fuel for exercise, though evidence for whether they actually enhance exercise performance is mixed. Protein supplements, usually in a palatable powdered form such as whey protein or rice protein, are also commonly used both for flavour and as a fuel for muscle growth and recovery. Electrolytes providing sodium, potassium and magnesium (and often others such as zinc, calcium, iron etc in smaller amounts) are often included to replace those lost due to sweating during heavy exercise, generally as a mixture of different salts, sometimes including exotic forms such as zinc monomethionine aspartate or calcium fructoborate which are supposed to be better absorbed or have other special properties. Electrolytes help the body perform homeostasis and prevent dehydration. Nitrate salts are commonly included (often as "beetroot extract") for their supposed benefits for endurance exercise. Sometimes this is achieved by using nitrate salts of other ingredients (e.g. arginine nitrate, creatine nitrate). Creatine, a natural chemical created in the kidneys and liver, is used supposedly to improve physical performance. It also promotes an increase in muscle growth. β-Alanine is a common ingredient found in 87% of leading pre-workout formulas.
A tetramer stain is a flow cytometry procedure that uses tetrameric proteins to detect and quantify T cells that are specific for a given antigen within a sample (e.g. blood, CSF). The tetramers used in the assay are made up of four major histocompatibility complex (MHC) molecules, which are found on the surface of most cells in the body. Cells produce MHC molecules containing peptides as a way to display the products those cells are making. One important function of MHC presentation is to communicate the presence of viruses, bacteria, cancerous mutations, or other antigens in a cell. If a T cell receptor recognises the peptide being presented by an MHC molecule, expansion of that T cell occurs. MHC tetramers are bioengineered to present a specific peptide that can be used to identify T cells with receptors that match that peptide. Tetramers are labeled with a fluorophore, allowing tetramer-bound T cells to be analyzed with flow cytometry. Quantification and sorting of T-cells by flow cytometry enables researchers to investigate immune response to e.g viral infection and vaccine administration as well as functionality of antigen-specific T cells. Generally, if a person's immune system has encountered a pathogen, the individual will possess T cells with specificity toward some peptide on that pathogen. If a tetramer stain specific for a pathogenic peptide (e.g. the Influenza virus A nucleoprotein (NP)) is positive, this indicates expansion of influenza A virus specific T cells in the subject.
Nanotechnology has been accepted as a tool for many industrial and domestic fields like gas monitoring systems, fire and toxic gas detectors, ventilation control, breath alcohol detectors and many more. Other sources state that nanotechnology has the potential to develop the pollutants sensing and detection methods that already exist. The ability to detect pollutants and sense unwanted materials will be heightened by the large surface area of nanomaterials and their high surface energy. The World Health Organization declared in 2014 that air contamination caused around 7 million deaths in 2012. This new technology could be an essential asset to this epidemic. The three ways that nanotechnology is being used to treat air pollution are nano-adsorptive materials, degradation by nanocatalysis, and filtration/separation by nanofilters. Nanoscale adsorbents being the main alleviator for many air pollution difficulties. Their structure permits a great interaction with organic compounds as well as increased selectivity and stability in maximum adsorption capacity. Other advantages include high electrical and thermal conductivities, high strength, high hardness. Target pollutants that can be targeted by nanomolecules are 〖NO〗_x, 〖CO〗_2, 〖NH〗_3, N_2, VOCs, Isopropyl vapor, 〖CH〗_3 OH gases, N_2 O, H_2 S. Carbon nanotubes specifically remove particles in many ways. One method is by passing them through the nanotubes where the molecules are oxidized; the molecules then are adsorbed on a nitrate species.
Sources: en.wikipedia.org
A maleimide moiety reacts with the thiol of cysteine-34, forming a covalent bond. The reaction occurs in circulation without enzymatic catalysis.
The group is intended to alter distribution and persistence, not receptor engagement. The peptide portion still binds the pituitary receptor, so the primary difference is duration rather than potency.
Not firmly. Early reports describe several days for the extended form, but independent confirmations are sparse, and values vary with assay method and study design.
It is a synthetic peptide modeled on growth hormone-releasing hormone. The molecule is used in research on pituitary growth hormone secretion. It differs from the natural hormone through several stabilizing substitutions.